Bionano Genomics, Inc. Financing Cash Flow
Bionano Genomics, Inc. (BNGO) reported Financing Cash Flow of -$9.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-10
- Bionano Genomics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$9.69M, a 759.84% decline year-over-year.
- Bionano Genomics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $657.00K, a 93.97% decline year-over-year.
- Bionano Genomics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $1.60M, a 58.79% decline year-over-year.
- Bionano Genomics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $10.08M, a 67.35% increase year-over-year.
- Bionano Genomics, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $24.04M.
- Bionano Genomics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$13.69M, a 112.02% decline from fiscal 2023.
- Bionano Genomics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $113.81M, a 394.70% increase from fiscal 2022.
- Bionano Genomics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $23.01M, a 93.15% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$9.04M 10-Q · filed 2026-08-10 | -$7.43M derived: sum of 3 quarters · filed 2026-08-10 | $2.64M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $657.00K 10-Q · filed 2026-05-13 | $2.26M derived: sum of 2 quarters · filed 2026-05-13 | $12.34M derived: sum of 3 quarters · filed 2026-05-13 | $13.80M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $11.68M derived: sum of 2 quarters · filed 2026-03-23 | $13.15M derived: sum of 3 quarters · filed 2026-08-10 | $24.04M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $10.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $11.54M derived: sum of 2 quarters · filed 2026-08-10 | $22.44M 10-Q · filed 2025-11-13 | $26.33M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $12.36M 10-Q · filed 2026-08-10 | $16.25M derived: sum of 3 quarters · filed 2026-08-10 | $22.27M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $10.89M 10-Q · filed 2026-05-13 | $14.78M derived: sum of 2 quarters · filed 2026-05-13 | $20.80M derived: sum of 3 quarters · filed 2026-05-13 | $18.82M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $9.91M derived: sum of 2 quarters · filed 2026-03-23 | $7.93M derived: sum of 3 quarters · filed 2026-03-23 | -$13.69M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $6.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $4.04M derived: sum of 2 quarters · filed 2025-11-13 | -$17.57M 10-Q · filed 2025-11-13 | $50.91M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$23.60M 10-Q · filed 2025-08-14 | $44.89M derived: sum of 3 quarters · filed 2025-08-14 | $57.48M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$21.62M 10-Q · filed 2025-05-14 | $46.87M derived: sum of 2 quarters · filed 2025-05-14 | $59.45M derived: sum of 3 quarters · filed 2025-05-14 | $77.33M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $68.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $81.07M derived: sum of 2 quarters · filed 2025-03-31 | $98.95M derived: sum of 3 quarters · filed 2025-03-31 | $113.81M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $12.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $30.47M derived: sum of 2 quarters · filed 2024-11-14 | $45.33M 10-Q · filed 2024-11-14 | $45.48M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $17.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $32.74M 10-Q · filed 2024-08-07 | $32.89M derived: sum of 3 quarters · filed 2024-08-07 | $55.54M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $14.86M 10-Q · filed 2024-05-08 | $15.01M derived: sum of 2 quarters · filed 2024-05-08 | $37.66M derived: sum of 3 quarters · filed 2024-05-08 | $37.86M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $22.80M derived: sum of 2 quarters · filed 2024-03-05 | $23.00M derived: sum of 3 quarters · filed 2024-03-05 | $23.01M 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $22.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $22.85M derived: sum of 2 quarters · filed 2023-11-08 | $22.86M 10-Q · filed 2023-11-08 | $24.83M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $203.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $210.00K 10-Q · filed 2023-08-09 | $2.18M derived: sum of 3 quarters · filed 2023-08-09 | $15.94M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $7.00K 10-Q · filed 2023-05-09 | $1.97M derived: sum of 2 quarters · filed 2023-05-09 | $15.74M derived: sum of 3 quarters · filed 2023-05-09 | -$1.42M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $15.73M derived: sum of 2 quarters · filed 2023-03-09 | -$1.43M derived: sum of 3 quarters · filed 2023-03-09 | $336.11M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $13.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$3.39M derived: sum of 2 quarters · filed 2022-11-03 | $334.14M 10-Q · filed 2022-11-03 | $365.83M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | -$17.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $320.38M 10-Q · filed 2022-08-04 | $352.06M derived: sum of 3 quarters · filed 2022-08-04 | $367.15M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $337.54M 10-Q · filed 2022-05-05 | $369.22M derived: sum of 2 quarters · filed 2022-05-05 | $384.31M derived: sum of 3 quarters · filed 2022-05-05 | $400.57M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $31.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $46.77M derived: sum of 2 quarters · filed 2022-03-01 | $63.04M derived: sum of 3 quarters · filed 2022-03-01 | $61.90M 10-K · filed 2022-03-01 | $61.90M 10-K · filed 2021-03-23 | |||
| 2020-09-30 | $15.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $31.35M derived: sum of 2 quarters · filed 2021-11-04 | $30.22M 10-Q · filed 2021-11-04 | $48.71M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $16.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $15.13M 10-Q · filed 2021-08-04 | $33.62M derived: sum of 3 quarters · filed 2021-08-04 | $33.84M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | -$1.14M 10-Q · filed 2021-05-13 | $17.36M derived: sum of 2 quarters · filed 2021-05-13 | $17.57M derived: sum of 3 quarters · filed 2021-05-13 | $18.39M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $18.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $18.71M derived: sum of 2 quarters · filed 2021-03-23 | $19.52M derived: sum of 3 quarters · filed 2021-03-23 | $30.38M 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | $218.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.03M derived: sum of 2 quarters · filed 2020-11-13 | $11.89M 10-Q · filed 2020-11-13 | $11.79M 10-Q · filed 2019-11-07 | $11.86M derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | $811.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $11.67M 10-Q · filed 2020-08-13 | $11.67M 10-Q · filed 2019-08-08 | $11.64M derived: sum of 3 quarters · filed 2020-08-13 | $30.90M derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | $10.86M 10-Q · filed 2020-06-18 | $10.86M 10-Q · filed 2019-05-09 | $10.83M derived: sum of 2 quarters · filed 2020-06-18 | $30.09M derived: sum of 3 quarters · filed 2020-06-18 | $33.31M derived: sum of 4 quarters · filed 2020-06-18 | |||
| 2018-12-31 | -$32.31K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $19.23M derived: sum of 2 quarters · filed 2020-03-10 | $22.45M derived: sum of 3 quarters · filed 2020-03-10 | $35.78M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $19.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $22.48M derived: sum of 2 quarters · filed 2019-11-07 | $35.81M 10-Q · filed 2019-11-07 | $37.28M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $3.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $16.55M 10-Q · filed 2019-08-08 | $18.02M derived: sum of 3 quarters · filed 2019-08-08 | |||||
| 2018-03-31 | $13.33M 10-Q · filed 2019-05-09 | $14.80M derived: sum of 2 quarters · filed 2019-05-09 | ||||||
| 2017-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $17.61M 10-K · filed 2019-03-14 | ||||||
| 2017-09-30 | $16.13M 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |